Biophage Pharma Inc. Announces the Conclusion of a

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Biophage Pharma Inc. Announces the Conclusion of a Conditional Asset Purchase Agreement

MONTREAL, March 20, 2015 (GLOBE NEWSWIRE) -- (NEX:BUG). Biophage Pharma Inc. (« Biophage ») announced today the conclusion of a conditional asset purchase agreement of all its assets and those of its subsidiary Biophage Inc as of March 10, 2015 with Phagelux Canada Inc. At the closing and only when all the terms of this offer are met, Phagelux Canada Inc. will own all assets including tangible and intangible assets, all Intellectual Property and equipment, as well as phage and bacterial libraries. The aggregate value of the transaction is US$ 750,000 (914,630 $CDN) comprising a closing payment of US$ 200,000 (243,900 $CDN) in cash and the remainder in common stock of the parent company of Phagelux Canada Inc., Phagelux Inc. An additional Equity payment of US$ 250,000 (304,880 $CDN) in common stock (Additional shares) could be issued to Biophage based on the performance of certain assets.

This transaction remains subject to approval by Biophage shareholders and the Autorité des marchés financiers (AMF), as well as NEX. In addition, the buyer will have completed the due diligence of the assets acquired and expressed total satisfaction and closed the A Round of Capital Raise; as well as other customary closing conditions in this type of transaction.

The parties to the Offer have agreed to make all commercially reasonable efforts to ensure that the Closing date can occur on or before May 31, 2015. However, since Closing of the Offering is subject to numerous conditions, including external factors to the parties, there is no insurance that this agreement will be executed.

Dr Mandeville, President and CEO of Biophage commented, «Biophage Pharma believes that the implementation of the proposed transaction will accelerate the pursuit of the objectives set by our corporation over the last 20 years while allowing shareholders to benefit from better business opportunities through the structure and the network of Phagelux Inc ».   

About Biophage Pharma Inc.

Biophage Pharma Inc. is a Canadian biotechnology company focused on the development of innovative phage-based technologies for the detection and management of pathogenic bacteria. Phage therapy offers a safe and environmental friendly solutions to food safety and the control of bacterial pathogens. Biophage Pharma is under cease trade of its shares since April 3, 2008 for failure to deposit its audited financial report as of November 3, 2007.

About Phagelux Canada Inc.

Phagelux Canada, Inc. is a subsidiary of Phagelux, Inc., a corporation that utilizes phages to solve bacterial contamination problems in multiple fields.

Forward-looking Statements

The information in this press release contains statements regarding financial results and future operating results. They also contain forward-looking statements with respect to partnerships and agreements and future opportunities. They also contain statements with respect to the management and development of intellectual property as well as other statements about future expectations, goals and plans of Biophage and Phagelux Inc. The words "may", "could", "should", "outlook", "believe", "project", "aim", "anticipate", "estimate" and similar words and expressions identify forward-looking statements. Actual results may vary materially from the expectations expressed by Biophage and Phagelux Inc depending on a number of risks and uncertainties. The latter relate to the capacity of the Buyer to close the A Round of Capital Raise in order to buy the assets and to transfer all permits in order to continue normal company operations. It is recommended to shareholders that these statements are predictions and given that actual events or results may differ materially from those anticipated in these forward-looking statements. Forward-looking statements herein reflect the expectations Biophage and Phagelux inc., consider reasonable in the current context and does not undertake to update these statements as a result of subsequent developments, unless required to do so under the applicable securities laws.

Biophage Pharma Inc Rosemonde Mandeville, M.B., Ch.B., PhD President and Chief Financial Officer (514) 496-1488

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 73

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 21

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 44

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 115

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 89

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 104

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
Six LIFE Photographers Bring History Into Florida Focus

Updated Category News Views 96

Seventy photographs can make a pretty loud argument when the historical record has been this lopsided. The Ashley Gibson Barnett Museum of Art at Florida Southern College has brought LIFE: Six Women Photographers to Lakeland, and it deserves more than the usual polite nod given to a traveling museum show. Open since November 14, 2026, and running through March 7, 2027,...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 313

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 40

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 61

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking AI Potential: VERSES Genius™ Surpasses Competitors

Updated Category News Views 353

VERSES Genius™ Agent Sets New Benchmark in AI Performance VERSES AI Inc., a pioneer in cognitive computing, is redefining intelligent systems with its innovative Genius™ toolkit. Recent evaluations against industry-leading benchmarks highlight its significant advancements in artificial intelligence. The preliminary results regarding the "Atari 100K Challenge" showcase...

Continue Reading
MKS Instruments Achieves Loan Repricing and Adds Prepayment

Updated Category News Views 356

MKS Instruments Achieves Loan Repricing and Adds Prepayment MKS Instruments, Inc. (NASDAQ: MKSI), a prominent global leader in enabling technologies, has made a significant leap in optimizing its financial structure. Recently, the company announced it has completed the repricing of its considerable secured tranche B term loans, which amount to a staggering $2.5 billion...

Continue Reading
Incredible Growth of Cheniere Energy: A 15-Year Journey

Updated Category News Views 238

The Remarkable Performance of Cheniere Energy Cheniere Energy, known by its trading symbol LNG, has consistently outperformed the market over the past 15 years. Investors in LNG have witnessed an incredible annualized return of 35.23%, exceeding the market by 22.77%. Currently, Cheniere Energy boasts a market capitalization of $53.26 billion, marking its growth trajectory...

Continue Reading
Adhara and ioBuilders Form New Powerhouse in Blockchain Solutions

Updated Category News Views 420

Adhara and ioBuilders Unite for Blockchain Innovation Adhara and ioBuilders have merged their expertise to create a leading provider of blockchain software products tailored specifically for financial institutions. This strategic alliance has resulted in a profitable company with a robust workforce of over 120 employees, distributed across various regions including the...

Continue Reading
Legal Action Against Lineage, Inc. Following Significant Stock Drop

Updated Category News Views 227

Overview of the Situation Surrounding Lineage, Inc. In recent times, Lineage, Inc. has found itself at the heart of a significant legal controversy following a dramatic 17% drop in its stock price. Leading with this news is the announcement of a class action lawsuit against the company and some of its top executives. Legal firm Bleichmar Fonti & Auld LLP is rallying...

Continue Reading